Handbook of Clinical Nanomedicine : Nanoparticles, Imaging, Therapy, and Clinical Applications: Jenny Stanford Series on Nanomedicine
Autor Raj Bawa, Gerald F. Audette, Israel Rubinsteinen Limba Engleză Hardback – 24 feb 2016
Preț: 2661.95 lei
Preț vechi: 3192.98 lei
-17% Nou
Puncte Express: 3993
Preț estimativ în valută:
509.43€ • 529.89$ • 420.56£
509.43€ • 529.89$ • 420.56£
Carte disponibilă
Livrare economică 24 martie-07 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789814669207
ISBN-10: 9814669202
Pagini: 1708
Ilustrații: 211 Illustrations, color; 73 Illustrations, black and white
Dimensiuni: 152 x 229 x 64 mm
Greutate: 2.13 kg
Ediția:1
Editura: CRC Press/ Taylor & Francis
Colecția Jenny Stanford Publishing
Seria Jenny Stanford Series on Nanomedicine
ISBN-10: 9814669202
Pagini: 1708
Ilustrații: 211 Illustrations, color; 73 Illustrations, black and white
Dimensiuni: 152 x 229 x 64 mm
Greutate: 2.13 kg
Ediția:1
Editura: CRC Press/ Taylor & Francis
Colecția Jenny Stanford Publishing
Seria Jenny Stanford Series on Nanomedicine
Public țintă
Academic and PostgraduateCuprins
Section I – Introduction and Beginnings. Section II – Nanoparticles, Nanodevices and Imaging. Section III – Clinical Applications of Nanotherapeutics.
Recenzii
"Dr. Bawa and his team have meticulously gathered the distilled experience of world-class researchers, clinicians and business leaders addressing the most salient issues confronted in product concept development and translation. Knowledge is power, particularly in nanomedicine translation, and this handbook is an essential guide that illustrates and clarifies our way to commercial success."
—Gregory Lanza, MD, PhD, Professor of Medicine and Oliver M. Langenberg Distinguished Professor, Washington University Medical School, USA
"This is an outstanding, comprehensive volume that crosscuts disciplines and topics fitting individuals from a variety of fields looking to become knowledgeable in medical nanotech research and its translation from the bench to the bedside."
—Shaker A. Mousa, PhD, MBA, Vice Provost and Professor of Pharmacology, Albany College of Pharmacy and Health Sciences, USA
"Masterful! This handbook will have a welcome place in the hands of students, educators, clinicians and experienced scientists alike. In a rapidly evolving arena, the authors have harnessed the field and its future by highlighting both current and future needs in diagnosis and therapies. Bravo!"
—Howard E. Gendelman, MD, Margaret R. Larson Professor and Chair, University of Nebraska Medical Center, USA
"It is refreshing to see a handbook that does not merely focus on preclinical aspects or exaggerated projections of nanomedicine. Unlike other books, this handbook not only highlights current advances in diagnostics and therapies but also addresses critical issues like terminology, regulatory aspects and personalized medicine."
—Gert Storm, PhD, Professor of Pharmaceutics, Utrecht University, The Netherlands
—Gregory Lanza, MD, PhD, Professor of Medicine and Oliver M. Langenberg Distinguished Professor, Washington University Medical School, USA
"This is an outstanding, comprehensive volume that crosscuts disciplines and topics fitting individuals from a variety of fields looking to become knowledgeable in medical nanotech research and its translation from the bench to the bedside."
—Shaker A. Mousa, PhD, MBA, Vice Provost and Professor of Pharmacology, Albany College of Pharmacy and Health Sciences, USA
"Masterful! This handbook will have a welcome place in the hands of students, educators, clinicians and experienced scientists alike. In a rapidly evolving arena, the authors have harnessed the field and its future by highlighting both current and future needs in diagnosis and therapies. Bravo!"
—Howard E. Gendelman, MD, Margaret R. Larson Professor and Chair, University of Nebraska Medical Center, USA
"It is refreshing to see a handbook that does not merely focus on preclinical aspects or exaggerated projections of nanomedicine. Unlike other books, this handbook not only highlights current advances in diagnostics and therapies but also addresses critical issues like terminology, regulatory aspects and personalized medicine."
—Gert Storm, PhD, Professor of Pharmaceutics, Utrecht University, The Netherlands
Notă biografică
Raj Bawa, MS, PhD , is president of Bawa Biotech LLC, a biotech/pharma consultancy and patent law firm based in Ashburn, Virginia that he founded in 2002. He is an inventor, entrepreneur, professor and registered patent agent licensed to practice before the US Patent & Trademark Office. Trained as a biochemist and microbiologist, he has been an active researcher for over two decades. He has extensive expertise in the pharmaceutical sciences, biotechnology, nanomedicine, drug delivery, biodefense, FDA regulatory issues, and patent law. Since 1999, he has held various adjunct faculty positions at Rensselaer Polytechnic Institute in Troy, NY, where he is currently an adjunct professor of biological sciences and where he received his doctoral degree in three years (biophysics/biochemistry). Since 2004, he has been an adjunct professor of natural and applied sciences at NVCC in Annandale, VA. He is a scientific advisor to Teva Pharmaceutical Industries, Ltd., Israel. He has served as a principal investigator of National Cancer Institute SBIRs and reviewer for both the National Institutes of Health and the National Science Foundation. In the 1990s, Dr. Bawa held various positions at the US Patent & Trademark Office, including primary examiner for 6 years. He is a life member of Sigma Xi, co-chair of the Nanotech Committee of the American Bar Association and serves on the Global Advisory Council of the World Future Society. He has authored over 100 publications, co-edited four texts and serves on the editorial boards of numerous peer-reviewed journals, including serving as a special associate editor of Nanomedicine (Elsevier) and an editor-in-chief of the Journal of Interdisciplinary Nanomedicine (Wiley). Some of Dr. Bawa's awards include the Innovations Prize from the Institution of Mechanical Engineers, London, UK (2008), the Key Award from Rensselaer's Office of Alumni Relations (2005) and the Lifetime Achievement Award from the
Descriere
The exciting advances in nanomedicine in the past two decades highlight the growing need for an authoritative and comprehensive reference that can be relied upon by scientists, clinicians, academics, industry, students, lawyers, and policy-makers alike. With this in mind, the Handbook of Clinical Nanomedicine: Nanoparticles, Imaging, Therapy, and Clinical Applications and its related companion volumes in the series aim to provide a broad survey of interconnected topics pertaining to clinical nanomedicine. This is the first volume in the series. Each volume is intended to be a stand-alone reference source, presented in a user-friendly format for easy access.
This handbook provides a comprehensive roadmap of basic research in nanomedicine as well as clinical applications. Unlike other handbooks in nanomedicine, it not only highlights current advances in diagnostics and therapies but also explores related issues such as nomenclature, terminology, regulatory aspects, and personalized medicine. All chapters contain keywords, figures in full color, author biographies, and an extensive list of references. The handbook is essential reading for both the novice and the expert in medicine, FDA law, intellectual property, biotechnology, pharmaceutical sciences, engineering, policy, future studies, ethics, licensing, commercialization, and toxicology. While bridging the gap between basic biomedical research, engineering, medicine, and law, the handbook provides a thorough understanding of nano’s potential to address medical problems from both the patient and the health provider’s perspective and current applications and their potential in a healthcare setting.
The editors have curated each chapter to reflect the most relevant and current information possible. Diversity within the evolving fields of nanomedicine and nanotherapy is reflected in the expertise of the distinguished contributing authors. As a result, the handbook’s multidisciplinary approach will attract a global audience. In short, the Handbook of Clinical Nanomedicine: Nanoparticles, Imaging, Therapy, and Clinical Applications promises to be a standard reference on any shelf in the expanding arena of nanomedicine. It will serve as a catalyst to further stimulate interest in this blossoming field.
This handbook provides a comprehensive roadmap of basic research in nanomedicine as well as clinical applications. Unlike other handbooks in nanomedicine, it not only highlights current advances in diagnostics and therapies but also explores related issues such as nomenclature, terminology, regulatory aspects, and personalized medicine. All chapters contain keywords, figures in full color, author biographies, and an extensive list of references. The handbook is essential reading for both the novice and the expert in medicine, FDA law, intellectual property, biotechnology, pharmaceutical sciences, engineering, policy, future studies, ethics, licensing, commercialization, and toxicology. While bridging the gap between basic biomedical research, engineering, medicine, and law, the handbook provides a thorough understanding of nano’s potential to address medical problems from both the patient and the health provider’s perspective and current applications and their potential in a healthcare setting.
The editors have curated each chapter to reflect the most relevant and current information possible. Diversity within the evolving fields of nanomedicine and nanotherapy is reflected in the expertise of the distinguished contributing authors. As a result, the handbook’s multidisciplinary approach will attract a global audience. In short, the Handbook of Clinical Nanomedicine: Nanoparticles, Imaging, Therapy, and Clinical Applications promises to be a standard reference on any shelf in the expanding arena of nanomedicine. It will serve as a catalyst to further stimulate interest in this blossoming field.